These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17665161)

  • 1. [Projects of the 6th European Framework Program].
    Thalmann G
    Urologe A; 2007 Sep; 46(9):1274-8. PubMed ID: 17665161
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer of the prostate--where are we now?
    Blandy J
    Practitioner; 1989 May; 233(1468):636, 639. PubMed ID: 2602296
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone metastases: improving the therapeutic index.
    Scher HI; Chung LW
    Semin Oncol; 1994 Oct; 21(5):630-56. PubMed ID: 7939753
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating bone metastases.
    Albert K
    Clin J Oncol Nurs; 2007 Apr; 11(2):193-7. PubMed ID: 17573268
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinocythemia.
    Basu S; Garewal G; Dey P
    J Assoc Physicians India; 1996 Jul; 44(7):502-3. PubMed ID: 9282620
    [No Abstract]   [Full Text] [Related]  

  • 7. [What is the value of digital rectal examination?].
    Lebiedz P; Kucharzik T
    Med Klin (Munich); 2004 Dec; 99(12):735-9; quiz 740-1. PubMed ID: 15599684
    [No Abstract]   [Full Text] [Related]  

  • 8. Coordination of research on internal dosimetry in Europe: the CONRAD project.
    Lopez MA; Etherington G; Castellani CM; Franck D; Hurtgen C; Marsh JW; Nosske D; Doerfel H; Andrasi A; Bailey M; Balashazy I; Battisti P; Bérard P; Berkowski V; Birchall A; Blanchardon E; Bonchuk Y; de Carlan L; Cantone MC; Challeton-de Vathaire C; Cruz-Suarez R; Davis K; Dorrian D; Giussani A; Le Guen B; Hodgson A; Jourdain JR; Koukouliou V; Luciani A; Malatova I; Molokanov A; Moraleda M; Muikku M; Oeh U; Puncher M; Rahola T; Ratia H; Stradling N
    Radiat Prot Dosimetry; 2007; 127(1-4):311-6. PubMed ID: 17686965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dissemination of secondaries of carcinoma into the bones (author's transl)].
    Moser H
    Med Klin; 1974 Apr; 69(17):745-9. PubMed ID: 4837492
    [No Abstract]   [Full Text] [Related]  

  • 10. The vanishing prostate cancer phenomenon.
    Loeb S; Schaeffer EM; Epstein JI
    Urology; 2010 Sep; 76(3):605-7. PubMed ID: 20079526
    [No Abstract]   [Full Text] [Related]  

  • 11. [Information on the Federation of National Academies of Medicine and similar institutions of the European Union].
    Auquier L
    Bull Acad Natl Med; 1995 Oct; 179(7):1409-14. PubMed ID: 8556414
    [No Abstract]   [Full Text] [Related]  

  • 12. A dual-targeted lentiviral vector homing in on prostate bone metastases.
    Hu Y; Stout D; Wu L
    Mol Ther; 2007 Nov; 15(11):1906-8. PubMed ID: 17948046
    [No Abstract]   [Full Text] [Related]  

  • 13. Creating a European Research Council.
    Initiative for Science in Europe (ISE)
    Science; 2004 Aug; 305(5685):776-7. PubMed ID: 15297647
    [No Abstract]   [Full Text] [Related]  

  • 14. Strengthening imaging research in Europe: the European Institute for Biomedical Imaging Research (EIBIR).
    Krestin GP
    JBR-BTR; 2009; 92(1):1-5. PubMed ID: 19358477
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding the biology of bone metastases: key to the effective treatment of prostate cancer.
    Logothetis CJ; Navone NM; Lin SH
    Clin Cancer Res; 2008 Mar; 14(6):1599-602. PubMed ID: 18347159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis and predictive factors in prostate cancer].
    Albiges-Sauvin L; Lévy A; Massard C; Fizazi K
    Bull Cancer; 2009 Apr; 96(4):439-49. PubMed ID: 19357018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
    Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
    Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looking forward in diagnostic pathology: the molecular superhighway.
    Abati A; Liotta LA
    Cancer; 1996 Jul; 78(1):1-3. PubMed ID: 8646703
    [No Abstract]   [Full Text] [Related]  

  • 19. Europe boosts genome resource centres...as German genomics gets cash windfall.
    Abbott A
    Nature; 2000 Nov; 408(6811):393. PubMed ID: 11100692
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
    Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
    Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.